Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2006

Open Access 01-10-2006 | Research article

Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis

Authors: James N Jarvis, Howard R Petty, Yuhong Tang, Mark Barton Frank, Philippe A Tessier, Igor Dozmorov, Kaiyu Jiang, Andrei Kindzelski, Yanmin Chen, Craig Cadwell, Mary Turner, Peter Szodoray, Julie L McGhee, Michael Centola

Published in: Arthritis Research & Therapy | Issue 5/2006

Login to get access

Abstract

Although strong epidemiologic evidence suggests an important role for adaptive immunity in the pathogenesis of polyarticular juvenile rheumatoid arthritis (JRA), there remain many aspects of the disease that suggest equally important contributions of the innate immune system. We used gene expression arrays and computer modeling to examine the function in neutrophils of 25 children with polyarticular JRA. Computer analysis identified 712 genes that were differentially expressed between patients and healthy controls. Computer-assisted analysis of the differentially expressed genes demonstrated functional connections linked to both interleukin (IL)-8- and interferon-γ (IFN-γ)-regulated processes. Of special note is that the gene expression fingerprint of children with active JRA remained essentially unchanged even after they had responded to therapy. This result differed markedly from our previously reported work, in which gene expression profiles in buffy coats of children with polyarticular JRA reverted to normal after disease control was achieved pharmacologically. These findings suggest that JRA neutrophils remain in an activated state even during disease quiescence. Computer modeling of array data further demonstrated disruption of gene regulatory networks in clusters of genes modulated by IFN-γ and IL-8. These cytokines have previously been shown to independently regulate the frequency (IFN-γ) and amplitude (IL-8) of the oscillations of key metabolites in neutrophils, including nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and superoxide ion. Using real-time, high-speed, single-cell photoimaging, we observed that 6/6 JRA patients displayed a characteristic defect in 12% to 23% of the neutrophils tested. Reagents known to induce only frequency fluctuations of NAD(P)H and superoxide ion induced both frequency and amplitude fluctuations in JRA neutrophils. This is a novel finding that was observed in children with both active (n = 4) and inactive (n = 2) JRA. A subpopulation of polyarticular JRA neutrophils are in a chronic, activated state, a state that persists when the disease is well controlled pharmacologically. Furthermore, polyarticular JRA neutrophils exhibit an intrinsic defect in the regulation of metabolic oscillations and superoxide ion production. Our data are consistent with the hypothesis that neutrophils play an essential role in the pathogenesis of polyarticular JRA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Førre Ø, Dobloug JH, Høyerall H, Thorsby E: HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum. 1983, 26: 35-38.CrossRefPubMed Førre Ø, Dobloug JH, Høyerall H, Thorsby E: HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum. 1983, 26: 35-38.CrossRefPubMed
2.
go back to reference Jarvis JN, Pousak T, Krenz M, Iobidze M, Taylor H: Complement activation and immune complexes in juvenile rheumatoid arthritis. J Rheumatol. 1993, 20: 114-117.PubMed Jarvis JN, Pousak T, Krenz M, Iobidze M, Taylor H: Complement activation and immune complexes in juvenile rheumatoid arthritis. J Rheumatol. 1993, 20: 114-117.PubMed
3.
go back to reference Jarvis JN, Taylor H, Iobidze M, Krenz M: Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study. J Rheumatol. 1994, 21: 1124-1127.PubMed Jarvis JN, Taylor H, Iobidze M, Krenz M: Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study. J Rheumatol. 1994, 21: 1124-1127.PubMed
4.
go back to reference Jarvis JN, Diebold MM, Chadwell MK, Iobidze M, Moore HT: Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis. Clin Exp Immunol. 1995, 100: 514-518.PubMedCentralCrossRefPubMed Jarvis JN, Diebold MM, Chadwell MK, Iobidze M, Moore HT: Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis. Clin Exp Immunol. 1995, 100: 514-518.PubMedCentralCrossRefPubMed
5.
go back to reference Eberhard BA, Laxer RM, Andersson U, Silverman ED: Local synthesis of both macrophage and T cell cytokines in synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol. 1994, 96: 260-266.PubMedCentralCrossRefPubMed Eberhard BA, Laxer RM, Andersson U, Silverman ED: Local synthesis of both macrophage and T cell cytokines in synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol. 1994, 96: 260-266.PubMedCentralCrossRefPubMed
6.
go back to reference Petty RE, Cassidy JT: Juvenile rheumatoid arthritis. Textbook of Pediatric Rheumatology. 2001, Philadelphia: WB Saunders Co, 262- Petty RE, Cassidy JT: Juvenile rheumatoid arthritis. Textbook of Pediatric Rheumatology. 2001, Philadelphia: WB Saunders Co, 262-
7.
go back to reference Jarvis JN: Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol. 1998, 10: 459-467.CrossRefPubMed Jarvis JN: Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol. 1998, 10: 459-467.CrossRefPubMed
8.
go back to reference Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest. 2000, 80: 617-653.CrossRefPubMed Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest. 2000, 80: 617-653.CrossRefPubMed
9.
go back to reference Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J: Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004, 50: 1286-1295. 10.1002/art.20125.CrossRefPubMed Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J: Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004, 50: 1286-1295. 10.1002/art.20125.CrossRefPubMed
10.
go back to reference Cassidy JT, Levinson JE, Brewer EJ: The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis. 1989, 38: 1-7.PubMed Cassidy JT, Levinson JE, Brewer EJ: The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis. 1989, 38: 1-7.PubMed
11.
go back to reference Jarvis JN, Pousak T, Krenz M: Detection of IgM rheumatoid factors by ELISA in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities. Pediatrics. 1992, 90: 945-949.PubMed Jarvis JN, Pousak T, Krenz M: Detection of IgM rheumatoid factors by ELISA in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities. Pediatrics. 1992, 90: 945-949.PubMed
12.
go back to reference Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Wallin B: Auranofin in the treatment of juvenile rheumatoid arthritis. Results of a double-blind, placebo-controlled trial. Arthritis Rheum. 1990, 33: 466-476.CrossRefPubMed Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Wallin B: Auranofin in the treatment of juvenile rheumatoid arthritis. Results of a double-blind, placebo-controlled trial. Arthritis Rheum. 1990, 33: 466-476.CrossRefPubMed
13.
go back to reference Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P, Centola M: Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R15-R32. 10.1186/ar1018.PubMedCentralCrossRefPubMed Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P, Centola M: Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R15-R32. 10.1186/ar1018.PubMedCentralCrossRefPubMed
14.
go back to reference Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M: Hypervariable genes – experimental error or hidden dynamics. Nucleic Acids Res. 2004, 32: e147-10.1093/nar/gnh146.PubMedCentralCrossRefPubMed Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M: Hypervariable genes – experimental error or hidden dynamics. Nucleic Acids Res. 2004, 32: e147-10.1093/nar/gnh146.PubMedCentralCrossRefPubMed
15.
go back to reference Kindzelskii AL, Eszes MM, Todd RF, Petty HR: Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils. Biophys J. 1997, 73: 1777-1784.PubMedCentralCrossRefPubMed Kindzelskii AL, Eszes MM, Todd RF, Petty HR: Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils. Biophys J. 1997, 73: 1777-1784.PubMedCentralCrossRefPubMed
16.
go back to reference Adachi Y, Kindzelskii AL, Ohno N, Yadomae T, Petty HR: Amplitude and frequency modulation of metabolic signals in leukocytes: synergistic role of IFN-gamma in IL-6- and IL-2-mediated cell activation. J Immunol. 1999, 163: 4367-4374.PubMed Adachi Y, Kindzelskii AL, Ohno N, Yadomae T, Petty HR: Amplitude and frequency modulation of metabolic signals in leukocytes: synergistic role of IFN-gamma in IL-6- and IL-2-mediated cell activation. J Immunol. 1999, 163: 4367-4374.PubMed
18.
go back to reference Amit A, Kindelzelski A, Zanoni J, Jarvis JN, Petty HR: Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations in migrating neutrophils. Cell Immunol. 1999, 194: 47-53. 10.1006/cimm.1999.1481.CrossRefPubMed Amit A, Kindelzelski A, Zanoni J, Jarvis JN, Petty HR: Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations in migrating neutrophils. Cell Immunol. 1999, 194: 47-53. 10.1006/cimm.1999.1481.CrossRefPubMed
19.
go back to reference Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N: Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem. 1991, 266: 7706-7713.PubMed Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N: Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem. 1991, 266: 7706-7713.PubMed
20.
go back to reference Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, Tessier PA: Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol. 2004, 76: 433-440. 10.1189/jlb.0603294.CrossRefPubMed Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, Tessier PA: Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol. 2004, 76: 433-440. 10.1189/jlb.0603294.CrossRefPubMed
21.
go back to reference Rouleau P, Vandal K, Ryckman C, Poubelle PE, Boivin A, Talbot M, Tessier PA: The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol. 2003, 107: 46-54. 10.1016/S1521-6616(02)00043-8.CrossRefPubMed Rouleau P, Vandal K, Ryckman C, Poubelle PE, Boivin A, Talbot M, Tessier PA: The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol. 2003, 107: 46-54. 10.1016/S1521-6616(02)00043-8.CrossRefPubMed
22.
go back to reference Vandal K, Rouleau P, Ryckman C, Talbot M, Tessier PA: Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol. 2003, 171: 2602-2609.CrossRefPubMed Vandal K, Rouleau P, Ryckman C, Talbot M, Tessier PA: Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol. 2003, 171: 2602-2609.CrossRefPubMed
24.
go back to reference Grom AA, Hirsch R: T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2000, 12: 420-424. 10.1097/00002281-200009000-00012.CrossRefPubMed Grom AA, Hirsch R: T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2000, 12: 420-424. 10.1097/00002281-200009000-00012.CrossRefPubMed
25.
go back to reference Carrasco R, Smith JA, Lovell D: Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs. 2004, 6: 137-146. 10.2165/00148581-200406030-00001.CrossRefPubMed Carrasco R, Smith JA, Lovell D: Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs. 2004, 6: 137-146. 10.2165/00148581-200406030-00001.CrossRefPubMed
26.
go back to reference Foell D, Roth J: Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004, 50: 3762-3771. 10.1002/art.20631.CrossRefPubMed Foell D, Roth J: Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004, 50: 3762-3771. 10.1002/art.20631.CrossRefPubMed
27.
go back to reference Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J: Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004, 50: 1286-1295. 10.1002/art.20125.CrossRefPubMed Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J: Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004, 50: 1286-1295. 10.1002/art.20125.CrossRefPubMed
28.
go back to reference Jarvis JN, Wang W, Zhao L, Xu C, Moore HT: In vitro induction of pro-inflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes. Arthritis Rheum. 1997, 40: 2039-2046.CrossRefPubMed Jarvis JN, Wang W, Zhao L, Xu C, Moore HT: In vitro induction of pro-inflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes. Arthritis Rheum. 1997, 40: 2039-2046.CrossRefPubMed
29.
go back to reference Xiao S, Xu C, Jarvis JN: C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. Evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC. Clin Exp Immunol. 2001, 125: 360-367. 10.1046/j.1365-2249.2001.01597.x.PubMedCentralCrossRefPubMed Xiao S, Xu C, Jarvis JN: C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. Evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC. Clin Exp Immunol. 2001, 125: 360-367. 10.1046/j.1365-2249.2001.01597.x.PubMedCentralCrossRefPubMed
30.
go back to reference Jiang K, Chen Y, Xu C, Jarvis JN: T Cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2003, 131: 61-67. 10.1046/j.1365-2249.2003.02046.x.PubMedCentralCrossRefPubMed Jiang K, Chen Y, Xu C, Jarvis JN: T Cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2003, 131: 61-67. 10.1046/j.1365-2249.2003.02046.x.PubMedCentralCrossRefPubMed
31.
go back to reference Ryckman C, Roubichaud GA, Roy J, Cantin R, Tremblay MJ, Tessier PA: HIV-1 Transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. J Immunol. 2002, 169: 3307-3313.CrossRefPubMed Ryckman C, Roubichaud GA, Roy J, Cantin R, Tremblay MJ, Tessier PA: HIV-1 Transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. J Immunol. 2002, 169: 3307-3313.CrossRefPubMed
32.
go back to reference Kindzelskii AL, Petty HR: Apparent role of traveling metabolic waves in oxidant release by living neutrophils. Proc Natl Acad Sci USA. 2002, 99: 9207-9212. 10.1073/pnas.132630999.PubMedCentralCrossRefPubMed Kindzelskii AL, Petty HR: Apparent role of traveling metabolic waves in oxidant release by living neutrophils. Proc Natl Acad Sci USA. 2002, 99: 9207-9212. 10.1073/pnas.132630999.PubMedCentralCrossRefPubMed
33.
go back to reference Petty HR: Neutrophil oscillations: temporal and spatiotemporal aspects of cell behavior. Immunol Res. 2001, 23: 85-94. 10.1385/IR:23:1:85.CrossRefPubMed Petty HR: Neutrophil oscillations: temporal and spatiotemporal aspects of cell behavior. Immunol Res. 2001, 23: 85-94. 10.1385/IR:23:1:85.CrossRefPubMed
34.
go back to reference Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J: Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43: 628-637. 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X.CrossRefPubMed Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J: Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43: 628-637. 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X.CrossRefPubMed
35.
go back to reference Wulffraat NM, Haas PJ, Frosch M, De Kleer IM, Vogl T, Brinkman DM, Quartier P, Roth J, Kuis W: Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis. 2003, 62: 236-241. 10.1136/ard.62.3.236.PubMedCentralCrossRefPubMed Wulffraat NM, Haas PJ, Frosch M, De Kleer IM, Vogl T, Brinkman DM, Quartier P, Roth J, Kuis W: Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis. 2003, 62: 236-241. 10.1136/ard.62.3.236.PubMedCentralCrossRefPubMed
36.
go back to reference Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J: Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003, 52: 847-853. 10.1136/gut.52.6.847.PubMedCentralCrossRefPubMed Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J: Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003, 52: 847-853. 10.1136/gut.52.6.847.PubMedCentralCrossRefPubMed
37.
go back to reference Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, Sorg C, Roth J: Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax. 2003, 58: 613-617. 10.1136/thorax.58.7.613.PubMedCentralCrossRefPubMed Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, Sorg C, Roth J: Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax. 2003, 58: 613-617. 10.1136/thorax.58.7.613.PubMedCentralCrossRefPubMed
38.
go back to reference Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ: Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol. 2005, 141: 248-253. 10.1001/archderm.141.2.248.CrossRefPubMed Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ: Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol. 2005, 141: 248-253. 10.1001/archderm.141.2.248.CrossRefPubMed
39.
go back to reference Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, et al: Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2004, 103: 2809-2815. 10.1182/blood-2003-07-2531.CrossRefPubMed Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, et al: Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2004, 103: 2809-2815. 10.1182/blood-2003-07-2531.CrossRefPubMed
Metadata
Title
Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis
Authors
James N Jarvis
Howard R Petty
Yuhong Tang
Mark Barton Frank
Philippe A Tessier
Igor Dozmorov
Kaiyu Jiang
Andrei Kindzelski
Yanmin Chen
Craig Cadwell
Mary Turner
Peter Szodoray
Julie L McGhee
Michael Centola
Publication date
01-10-2006
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2006
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2048

Other articles of this Issue 5/2006

Arthritis Research & Therapy 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine